ImmunoGen Announces Investigational New Drug Application for IMGN632 for Hematological Malignancies is Active - https://finance.yahoo.com/news/immunogen-announces-investigational-drug-application-120000924.html
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2017 Financial Results - http://crweworld.com/article/news-p...cuss-its-third-quarter-2017-financial-results
Updating thread - 1/5/18 news - ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632 https://finance.yahoo.com/news/immunogen-starts-phase-study-leukemia-184106776.html
updating thread with latest news - ImmunoGen Announces Successful Completion of Interim Analysis for FORWARD I Phase 3 Trial of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer - https://finance.yahoo.com/news/immunogen-announces-successful-completion-interim-200100911.html
Giving all heads up here - offering closed so should be heading back up to at least offering pps. Sold swing this morning & then got tied up with another play so missed dip but might get another chance.
Games are being played here BUT gotta pay those that bought $11 offering price sooner or later lol - ImmunoGen Announces FDA Fast Track Designation for Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer - https://finance.yahoo.com/news/immunogen-announces-fda-fast-track-120000668.html
ImmunoGen Announces Sale of Residual Kadcyla Royalties - https://finance.yahoo.com/news/immunogen-announces-sale-residual-kadcyla-210100122.html
am out of this stock and think i am officially done with it. Too much manipulation lately. Saw 100K buy go through and ticker didn't even move but moved (down) with 100 sell orders - go figure unreal - still watching this thing. Some nice buys and ticker pretty much standing still - how do they do that?
